EIR Ventures
Venture capitalStockholm · Seed–Growth · 10 people tracked
Investment thesis
Eir Ventures invests in innovative medicine, backing Nordic life-science innovation intended to advance global health and improve millions of lives while delivering strong returns fund after fund. Its investment approach is built on a triad it applies to every portfolio company: transformative potential, excellence in execution, and scalability. The firm takes an active ownership role, creating companies and holding board seats, chairpersonships, and even CEO roles. It emphasizes translating rapidly evolving scientific innovations into business opportunities and patient benefits, and works with international syndication partners across the Nordics, Europe, and the US.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from the firm's website & public directories
What they invest in
from 4 of 26 portfolio companiesBiotech ×4Deep Tech ×3Medical Devices ×2AI & Machine Learning ×1Digital Health ×1Healthtech ×1Longevity ×1
HQs:Denmark×1Sweden×1United States×1
Investments · 26 tracked
founders shown can be your intro pathAdvancing potentially best-in-class therapeutics for myeloproliferative neoplasms.
Copenhagen, US
Board seatStephan Christgau· per SEC Form D · $64.2M raise · filed Nov 2020
Moleculent develops biological discovery and disease understanding tools for scientists.
AI & Machine LearningBiotechDeep Tech
Fredrik Roos(CTO & Co-founder)
Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression.
BiotechDeep TechHealthtechMedical Devices<UNKNOWN>
Michal Minczuk(Co-Founder)Gabriel Martinez(Chief Scientific Officer & Co-Founder)Claes Gustafsson(Co-Founder)Maria Falkenberg(Co-Founder)Nils-Göran Larsson(Co-Founder)Jay Parrish(Chief Executive Officer & Chairman of the Board)
Attgeno is a biotech company developing nitric oxide-based therapies, with a focus on chronic pulmonary hypertension.
BiotechDigital HealthMedical DevicesStockholm, SE
Lars E. Gustafsson(Co-founder (deceased))Magnus Persson(Chairman of the Board)
Swedish biopharmaceutical company developing novel potassium-competitive acid blockers for faster and more effective treatment of GERD.
Copenhagen-based oncology company developing treatments for acute myeloid leukemia and other cancer types based on University of Copenhagen research.
NASDAQ-listed company based on Lund University research developing galectin-3 targeting therapies for idiopathic pulmonary fibrosis and other fibrotic diseases.
GutCRINE is a biotech company applying human gut microbiome, metagenomics, and metabolomics research to identify bacterially derived compounds and biomarkers for cardiometabolic and metabolic diseases.
BiotechDeep TechLongevityCopenhagen, DK
Oluf Pedersen(CSO & Co-founder)Yong Fan(COO & Co-founder)Tobias Horneman-Thielcke(CEO)
Enzyme-based topical therapy for hidradenitis suppurativa developed by former Novozymes scientist.
Danish biotech developing non-opioid restorative treatments for chronic pain, hearing loss and sensory neuron disorders.
Stockholm-based life science tools company studying cell-cell interactions using innovative tissue-context approaches.
Mitochondrial biology-focused biotech founded by leading academics in the field, developing novel therapeutics.
Swedish digital health platform implementing value-based care monitoring for outpatient surgery to improve quality, patient satisfaction and healthcare efficiency.
Gothenburg University spin-out developing first-in-class sortilin inhibitor therapies targeting metastasis and growth of aggressive cancers.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does EIR Ventures invest at?
- EIR Ventures invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does EIR Ventures focus on?
- EIR Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is EIR Ventures located?
- EIR Ventures is headquartered in Stockholm, SE.
- Does EIR Ventures lead rounds?
- Yes, EIR Ventures leads investment rounds.
Media · Podcasts & interviews
featuring the team12: Investing in Biotech, with Lovisa Backemar, Principal at Eir Ventures
Investing & Other Stories Podcast · Lovisa Backemar
Similar investors
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.
Abingworth is a life science venture capital firm that backs early-stage biopharma and biotech companies, helping entrepreneurs translate scientific discoveries into new therapeutics.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.